Antiosteoporosis Effect of Bryodulcosigenin on Ovariectomy-induced Osteoporosis in Experimental Rats

Overview

Journal Acta Cir Bras

Specialty General Surgery

Date 2024 Apr 24

PMID 38656061

Authors

Kai Sun

Lin Qin

Affiliations

Soon will be listed here.

Abstract

Purpose: Osteoporosis is a bone disease which commonly occurred in postmenopausal women. Almost 10 percent of world population and approximately 30% of women (postmenopausal) suffer from this disease. Alternative medicine has great success in the treatment of osteoporosis disease. Bryodulcosigenin, a potent phytoconstituent, already displayed the anti-inflammatory and antioxidant effect. In this study, we made effort to analyze the antiosteoporosis effect of bryodulcosigenin against ovariectomy (OVX) induced osteoporosis in rats.

Methods: Swiss albino Wistar rats were grouped into fIve groups and given an oral dose of bryodulcosigenin (10, 20 and 30 mg/kg) for eight weeks. Body weight, uterus, bone mineral density, cytokines, hormones parameters, transforming growth factor (TGF)-β, insulin-like growth factor (IGF), osteoprotegerin (OPG), receptor activator of nuclear factor kappa-Β ligand (RANKL), and its ratio were estimated.

Results: Bryodulcosigenin significantly (p < 0.001) suppressed the body weight and enhanced the uterine weight and significantly (p < 0.001) increased the bone mineral density in whole femur, caput femoris, distal femur and proximal femur. Bryodulcosigenin significantly (P < 0.001) altered the level of biochemical parameters at dose dependent manner, significantly (P < 0.001) improved the level of estrogen and suppressed the level of follicle stimulating hormone and luteinizing hormone. Bryodulcosigenin significantly (P < 0.001) improved the level of OPG and suppressed the level of RANKL.

Conclusions: Bryodulcosigenin reduced the cytokines level and suppressed the TGF-β and IGF. We concluded that bryodulcosigenin is an antiosteoporosis medication based on the findings.

References

Zhang Z, Zhao Q, Liu T, Zhao H, Wang R, Li H . Effect of Vicenin-2 on ovariectomy-induced osteoporosis in rats. Biomed Pharmacother. 2020; 129:110474. DOI: 10.1016/j.biopha.2020.110474. View

Wang Q, Huo X, Wang J, Wang D, Zhu Q, Liu B . Rutin prevents the ovariectomy-induced osteoporosis in rats. Eur Rev Med Pharmacol Sci. 2017; 21(8):1911-1917. View

Nakano K, Kanai Y, Murakami K, Takaishi Y . Cucurbitacin glycosides from Cabeça-de-negro. Phytochemistry. 1995; 39(1):209-11. DOI: 10.1016/0031-9422(94)00869-u. View

Jyotsna V . Postmenopausal hormonal therapy: Current status. Indian J Endocrinol Metab. 2013; 17(Suppl 1):S45-9. PMC: 3830366. DOI: 10.4103/2230-8210.119504. View

Al Saedi A, Stupka N, Duque G . Pathogenesis of Osteoporosis. Handb Exp Pharmacol. 2020; 262:353-367. DOI: 10.1007/164_2020_358. View

Li M, Hao L, Li L, Liu L, Chen G, Jiang W . Cinnamtannin B-1 Prevents Ovariectomy-Induced Osteoporosis Attenuating Osteoclastogenesis and ROS Generation. Front Pharmacol. 2020; 11:1023. PMC: 7365944. DOI: 10.3389/fphar.2020.01023. View

Lewiecki E . Osteoporosis: Treat-to-Target. Curr Osteoporos Rep. 2017; 15(2):103-109. DOI: 10.1007/s11914-017-0350-7. View

Wang J, Zhang W, Yu C, Zhang X, Zhang H, Guan Q . Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation. PLoS One. 2015; 10(8):e0134986. PMC: 4524683. DOI: 10.1371/journal.pone.0134986. View

Pisani P, Renna M, Conversano F, Casciaro E, Di Paola M, Quarta E . Major osteoporotic fragility fractures: Risk factor updates and societal impact. World J Orthop. 2016; 7(3):171-81. PMC: 4794536. DOI: 10.5312/wjo.v7.i3.171. View

10.

Xu H, Liu T, Hu L, Li J, Gan C, Xu J . Effect of caffeine on ovariectomy-induced osteoporosis in rats. Biomed Pharmacother. 2019; 112:108650. DOI: 10.1016/j.biopha.2019.108650. View

11.

Wu K, Gong Z, Zou L, Ye H, Wang C, Liu Y . inhibits oestrogen deficiency and hyperlipidaemia-induced bone loss by upregulating nuclear factor (erythroid-derived 2)-like 2 in female rats. J Orthop Translat. 2019; 19:106-117. PMC: 6896726. DOI: 10.1016/j.jot.2019.03.002. View

12.

Yang D, Yang M . The Role of Macrophage in the Pathogenesis of Osteoporosis. Int J Mol Sci. 2019; 20(9). PMC: 6539137. DOI: 10.3390/ijms20092093. View

13.

Zhang D, Zhang S, Jiang K, Li T, Yan C . Bioassay-guided isolation and evaluation of anti-osteoporotic polysaccharides from Morinda officinalis. J Ethnopharmacol. 2020; 261:113113. DOI: 10.1016/j.jep.2020.113113. View

14.

Liu H, Zhang H, Fan H, Tang S, Weng J . The preventive effect of Cuscutae Semen polysaccharide on bone loss in the ovariectomized rat model. Biomed Pharmacother. 2021; 130:110613. DOI: 10.1016/j.biopha.2020.110613. View

15.

Wolski H, Drews K, Bogacz A, Kaminski A, Barlik M, Bartkowiak-Wieczorek J . The RANKL/RANK/OPG signal trail: significance of genetic polymorphisms in the etiology of postmenopausal osteoporosis. Ginekol Pol. 2016; 87(5):347-52. DOI: 10.5603/GP.2016.0014. View

16.

Giustina A, Mazziotti G, Canalis E . Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008; 29(5):535-59. PMC: 2726838. DOI: 10.1210/er.2007-0036. View

17.

Saleh N, Saleh H . Olive oil effectively mitigates ovariectomy-induced osteoporosis in rats. BMC Complement Altern Med. 2011; 11:10. PMC: 3045997. DOI: 10.1186/1472-6882-11-10. View

18.

Ukiya M, Akihisa T, Yasukawa K, Tokuda H, Toriumi M, Koike K . Anti-inflammatory and anti-tumor-promoting effects of cucurbitane glycosides from the roots of Bryonia dioica. J Nat Prod. 2002; 65(2):179-83. DOI: 10.1021/np010423u. View

19.

Zhang Y, Liu M, He Y, Deng N, Chen Y, Huang J . Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression. Int J Immunopathol Pharmacol. 2020; 34:2058738420941762. PMC: 7370339. DOI: 10.1177/2058738420941762. View

20.

Liu H, Xiong Y, Wang H, Yang L, Wang C, Liu X . Effects of water extract from epimedium on neuropeptide signaling in an ovariectomized osteoporosis rat model. J Ethnopharmacol. 2018; 221:126-136. DOI: 10.1016/j.jep.2018.04.035. View